Analysis of Lijun International (01355.HK) Becoming a Hong Kong Stock Hot Stock Due to Business Transformation

This analysis is based on information from the East Money App Hot List[0]. The core catalyst for Lijun International (01355.HK) becoming a hot stock on the Hong Kong Stock Surge List is its business transformation moves: the company announced the acquisition of a 37.5% indirect stake in Biosysen, a synthetic biology infrastructure supplier, for HK$22 million, and plans to rename itself “Biosystem Engineering Limited” to align with its new business direction. According to Futunn information[0], the current price of the stock is HK$0.120. Although due to tool limitations, no data on the day’s price change and trading volume was obtained, as a hot stock, its trading volume is expected to be higher than the average level.

1. The business transformation into the synthetic biology field is the core driver of market attention. As a high-growth track, synthetic biology-related companies often receive positive attention from investors, and the company’s transformation moves have successfully attracted market attention.
2. The low share price (HK$0.120) characteristic makes it easier to trigger market fluctuations and investor participation when major positive news emerges, thus entering the hot list.

: The transformation into the synthetic biology field provides the company with a new business growth point. If it can successfully integrate Biosysen’s resources and achieve breakthroughs in this field, it is expected to enhance the company’s long-term value.
: There are uncertainties in the new business field, including acquisition integration risks, technology R&D risks, and market competition risks; the company’s share price is low and volatility is high, so investors need to pay attention to short-term price fluctuation risks.

Lijun International (01355.HK) has become a Hong Kong stock hot stock due to its business transformation into the synthetic biology field, with transformation moves including the acquisition of Biosysen’s stake and renaming. The current share price is HK$0.120, and the market has positive sentiment towards its transformation, but attention needs to be paid to the uncertainties in the new business field and the volatility risks brought by the low share price.